Managing Spasticity Following Spinal Cord Injury

Marie Sarah^*
*Correspondence: Marie Sarah, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, USA, Email:

Introduction

Spinal cord injury often leads to various complications, one of the most common being spasticity. Spasticity is a condition characterized by involuntary muscle contractions and stiffness, which can significantly impact the quality of life for individuals with SCI. Effective management of spasticity is crucial in improving functional outcomes and enhancing overall well-being. Spasticity results from disrupted communication between the brain and the spinal cord due to SCI. It leads to exaggerated reflexes, muscle tightness, and spasms, which can affect mobility, posture, and daily activities. The severity of spasticity varies among individuals, with some experiencing mild discomfort and others facing more debilitating symptoms. Excessive spasticity can limit movement and hinder functional abilities.

Description

By reducing spasticity, individuals with SCI can regain better control over their muscles and enhance their mobility. Severe spasticity can contribute to secondary complications such as joint contractures, pressure ulcers, and muscle atrophy. Effective management helps prevent these complications and promotes overall health. Reduced spasticity leads to decreased pain, improved comfort, and better participation in daily activities, ultimately enhancing the quality of life for individuals with SCI. Physical therapy plays a crucial role in spasticity management. Therapeutic exercises, stretching routines, and range of motion activities help improve muscle flexibility, reduce spasms, and enhance motor control [1].

Medications such as muscle relaxants, anti-spasticity drugs, and nerve blockers may be prescribed to alleviate spasticity symptoms. These medications target specific pathways involved in muscle control and can provide relief for some individuals. For severe spasticity that is not adequately controlled with oral medications, intrathecal baclofen therapy may be considered. This involves delivering baclofen directly into the spinal fluid using an implanted pump, providing targeted relief with lower systemic side effects. Botulinum toxin injections can be used to target specific muscles affected by spasticity. This treatment helps relax overactive muscles and can be particularly beneficial for focal spasticity in areas such as the upper limbs or lower limbs [2,3]

Orthotic devices, braces, and assistive devices such as splints or orthopedic shoes can support proper alignment, reduce contractures, and improve mobility in individuals with spasticity. FES involves using electrical stimulation to activate specific muscles or nerve pathways. It can help manage spasticity by promoting muscle relaxation, improving circulation, and facilitating functional movements. Managing spasticity following SCI requires a collaborative approach involving healthcare professionals, therapists, caregivers, and individuals with SCI themselves. A comprehensive treatment plan should be tailored to each individual's needs, considering factors such as the level and severity of injury, functional goals, and preferences [4,5]. Advancements in research and technology continue to drive innovation in spasticity management. Emerging therapies, such as neurostimulation techniques, regenerative medicine approaches, and novel pharmacological agents, hold promise in providing more targeted and effective treatments for spasticity following SCI.

Conclusion

Managing spasticity following spinal cord injury is essential for optimizing functional outcomes and improving the quality of life for individuals affected by this condition. Through a combination of physical therapy, medications, assistive devices, and innovative treatments, healthcare providers can help individuals with SCI regain control over their muscles, reduce discomfort, and enhance their overall well-being. Continued research and collaboration within the medical community will further advance spasticity management strategies, offering hope for improved outcomes and increased independence for individuals living with SCI.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Lance, James W. "The control of muscle tone, reflexes, and movement: Robert Wartenbeg Lecture." Neur 30 (1980): 1303-1303.

   Google Scholar, Crossref

2. Pandyan, AnandD, M. Gregoric, M. P. Barnes and D. Wood, et al. "Spasticity: clinical perceptions, neurological realities and meaningful measurement." Disabil Rehabil 27 (2005): 2-6.

   Google Scholar, Crossref, Indexed at

3. Holtz, Kaila A, Rachel Lipson, Vanessa K. Noonan and Brian K. Kwon, et al. "Prevalence and effect of problematic spasticity after traumatic spinal cord injury." Arch Phys Med Rehabil 98 (2017): 1132-1138.

   Google Scholar, Crossref, Indexed at

4. Sköld, Camilla, Richard Levi and Åke Seiger. "Spasticity after traumatic spinal cord injury: Nature, severity, and location." Arch Phys Med Rehabil 80 (1999): 1548-1557.

   Google Scholar, Crossref, Indexed at

5. Mukherjee, Angshuman and Ambar Chakravarty. "Spasticity mechanisms–for the clinician." Front Neurol 1 (2010): 149.

   Google Scholar, Crossref, Indexed at